When Curtain Falls: 4+7 To 4+N Signals End To Branded Generics In China?

 
• By Brian Yang
  
Shanghai
EXPANSION OF SHANGHAI-INITIATED '4+7' SCHEME TO BRING PRICE PRESSURE ON BRANDED GENERICS • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia